Note: The job is a remote job and is open to candidates in USA. Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Director, Global Forecasting role involves strategic thinking and expertise to provide critical contributions to disease area strategy, life-cycle planning, and product and portfolio decisions, including developing and communicating key strategic and revenue forecast assumptions.
Responsibilities
- Develops and maintains long-term forecast models and scenario plans for RevMed’s products across indications
- Provides portfolio level views and analyses to support organizational decision making via streamline models and consolidation processes
- Communicates and aligns key internal stakeholders around key forecast assumptions
- Understands complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics and uses this knowledge to develop strategic forecasts and plans
- Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans
- Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk
- Participates in cross-functional teams to gather input for functional activities, and ensure alignment
- Partners closely with other Insights and Analytics functions (Market Research, Data Analytics, Competitive Intelligence) to inform the forecast
- Works closely with Pipeline Marketing, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making
- Works closely with Regional forecasting leads to ensure consistency and understand differences in forecasts
- Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future
- Collaborates with vendor partners to manage various deliverables and analyses
Skills
- Bachelor's degree required (MBA preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a related analytics/forecasting role
- Experience developing long-range patient-based forecasts for oncology products
- Experience supporting pipeline and portfolio decision making and supporting executional strategy for pipeline analytics and insights
- Track record of being a collaborative team player, and adaptive to meet the needs of a growing business
- Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships
- Demonstrated ability to influence senior management and key business partners
- Proven experience in a smaller, rapidly growing, company
- Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
- Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication
- Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients
- 8+ years of experience in patient-based forecasting with focus in Oncology
- Experience with targeted oncolytics
- Experience working with Global teams
- Demonstrated ability to synthesize complex information and influence decision-making at the executive level
Benefits
- Competitive cash compensation
- Robust equity awards
- Strong benefits
- Significant learning and development opportunities
Company Overview
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists. It was founded in 2015, and is headquartered in Redwood City, California, USA, with a workforce of 1001-5000 employees. Its website is https://www.revmed.com.Company H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships, with 5 in 2026, 13 in 2025, 18 in 2024, 15 in 2023, 8 in 2022, 1 in 2021, 2 in 2020. Please note that this does not guarantee sponsorship for this specific role.